RIM
AMED

RS Investment Management’s Amedisys AMED Stock Holding History

RS Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$40.5M Sell
801,563
-519
-0.1% -$26.2K 0.42% 79
2016
Q1 		$38.8M Buy
+802,082
New +$30.9M 0.38% 91

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RS Investment Management's AMED Position: Q2 2016 in Review

RS Investment Management reduced its Amedisys (AMED) stake by 0.06% in Q2 2016, selling an estimated $26.2K and leaving 801,563 shares worth $40.5M. The position accounts for 0.42% of the portfolio, ranked #79.

RS Investment Management first reported a position in AMED in Q1 2016 and has held it in 2 quarters since. 169 funds tracked by Wall St. Rank hold AMED as of Q2 2016.

  • RS Investment Management held 801,563 shares of Amedisys worth $40.5M as of Q2 2016.
  • RS Investment Management sold 519 Amedisys shares in Q2 2016, an estimated $26.2K.
  • Amedisys made up 0.42% of RS Investment Management's portfolio in Q2 2016, its #79 holding.
  • RS Investment Management first reported a position in Amedisys in Q1 2016 and has held it in 2 quarters since.
  • 169 funds tracked by Wall St. Rank held Amedisys as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.